MA S2695 | 2021-2022 | 192nd General Court
Status
Spectrum: Moderate Partisan Bill (Democrat 11-1-1)
Status: Engrossed on February 10 2022 - 50% progression, died in chamber
Action: 2023-01-03 - No further action taken
Text: Latest bill text (Introduced) [PDF]
Status: Engrossed on February 10 2022 - 50% progression, died in chamber
Action: 2023-01-03 - No further action taken
Text: Latest bill text (Introduced) [PDF]
Summary
Relative to pharmaceutical access, costs and transparency (being the text of Senate, No. 2651, printed as amended).
Title
Relative to pharmaceutical access, costs and transparency
Sponsors
History
| Date | Chamber | Action |
|---|---|---|
| 2023-01-03 | House | No further action taken |
| 2022-02-15 | House | Read; and referred to the committee on House Ways and Means |
| 2022-02-10 | Senate | Passed to be engrossed -see Roll Call #129 (Yeas 39 to Nays 1) |
| 2022-02-10 | Senate | Text of S2651, printed as amended |
Same As/Similar To
S771 (Similar To) 2022-02-10 - New draft substituted, see S2651
S2651 (Similar To) 2022-02-10 - Reprinted as amended, see S2695
S2651 (Similar To) 2022-02-10 - Reprinted as amended, see S2695
Massachusetts State Sources
| Type | Source |
|---|---|
| Summary | https://malegislature.gov/Bills/192/S2695 |
| Text | https://malegislature.gov/Bills/192/S2695.pdf |
